Purpose. The efficacy and safety of granulocyte colony-stimulating factor (G-CSF) in critically ill patients with severe sepsis or septic shock were evaluated. Summary. The medical literature was ...

The European Organisation for Research and Treatment of Cancer (EORTC) has recently produced guidelines for the use of G-CSF in adults with lymphomas and solid tumors undergoing chemotherapy.

Sutro Biopharma (STRO) announced expanded data in a late-breaking oral presentation from the dose-optimization portion of the REFRalphaME-O1 trial ...

Luveltamab tazevibulin demonstrated activity in an ongoing phase 2/3 trial of patients with FRα-positive, platinum-resistant ovarian cancer.

CSF oligoclonal bands is a test ordered by physicians when serious health concerns related to your central nervous system arise. Here’s what you need to know about it. If your physician suspects ...

The report delivers a comprehensive analysis of global biologics sales. Covering cancer antibodies, non-TNF inflammatory mAbs, biosimilars, gene therapy, RNA-based drugs, and more, the report provides ...

Pexegra TM is a long-acting G-CSF biosimilar indicated to decrease the incidence of infection, as manifested by febrile neutropenia, in patients with non-myeloid malignancies receiving ...

Safety was consistent across dosing groups, with no new safety signals observed and neutropenia well-managed. The majority of patients across both dose cohorts received prior bevacizumab. The ...

Clinical studies examining the use of G-CSF in critically ill patients without hematologic disease and immunosuppression included mostly patients with severe sepsis and septic shock. These studies ...